Compounds > satavaptan
Page last updated: 2024-09-04

satavaptan and Cardiac Failure

satavaptan has been researched along with Cardiac Failure in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's8 (53.33)29.6817
2010's6 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwao, H; Izumi, Y; Miura, K1
Boerrigter, G; Burnett, JC; Costello-Boerrigter, LC1
Haass, M1
Villabona, C1
Aronson, D; Krum, H; Mueller, M; Verbalis, JG1
Konstam, MA; Udelson, JE1
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N1
Dabrowska, MD; Krysiak, R; Okopień, B1
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P1
Ghali, JK1
Abassi, ZA; Abu-Saleh, N; Azzam, ZS; Bishara, B; Hoffman, A; Karram, T; Nitecki, S; Rubinstein, I; Shiekh, H; Winaver, J1
Serradeil-Le Gal, C1
Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J1
Martinez-Castelao, A1

Reviews

12 review(s) available for satavaptan and Cardiac Failure

ArticleYear
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling

2014
Pharmacology of vasopressin antagonists.
    Heart failure reviews, 2009, Volume: 14, Issue:2

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Benzodiazepines; Heart Failure; Humans; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2009
[Vasopressin receptor antagonists and heart failure].
    Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:11

    Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan

2009
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance

2011
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan

2012
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins

2003
Therapeutic potential of vasopressin receptor antagonists.
    Drugs, 2007, Volume: 67, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2007
Mechanisms, risks, and new treatment options for hyponatremia.
    Cardiology, 2008, Volume: 111, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Diuretics; Heart Failure; Hospitalization; Humans; Hyponatremia; Hypovolemia; Morpholines; Prognosis; Risk Factors; Saline Solution, Hypertonic; Spiro Compounds

2008
Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
    Advances in experimental medicine and biology, 1998, Volume: 449

    Topics: Adenylyl Cyclases; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Deamino Arginine Vasopressin; Dogs; Heart Failure; Humans; Kidney; Morpholines; Rats; Rats, Inbred BB; Receptors, Vasopressin; Spiro Compounds; Water-Electrolyte Imbalance

1998
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.
    Experimental physiology, 2000, Volume: 85 Spec No

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hypertension; Morpholines; Receptors, Vasopressin; Spiro Compounds; Tolvaptan

2000
SR-121463. Sanofi-Synthélabo.
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:10

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Glaucoma; Heart Failure; Humans; Hypertension; Morpholines; Spiro Compounds; Structure-Activity Relationship

2001

Trials

1 trial(s) available for satavaptan and Cardiac Failure

ArticleYear
Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.
    European journal of heart failure, 2011, Volume: 13, Issue:3

    Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Body Weight; Double-Blind Method; Female; Heart Failure; Humans; Hyponatremia; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Treatment Outcome; Vasopressins; Young Adult

2011

Other Studies

2 other study(ies) available for satavaptan and Cardiac Failure

ArticleYear
Hyponatraemia and vasopressin in heart failure: markers or mediators?
    European journal of heart failure, 2011, Volume: 13, Issue:3

    Topics: Antidiuretic Hormone Receptor Antagonists; Heart Failure; Humans; Hyponatremia; Morpholines; Sodium; Spiro Compounds; Vasopressins

2011
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiomegaly; Disease Models, Animal; Diuresis; Drug Administration Schedule; Heart Failure; Indoles; Kidney Function Tests; Male; Morpholines; Organ Size; Osmolar Concentration; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sodium; Spiro Compounds; Vasoconstriction

2008